Earnings Feed
Start Free
Home/Filings/4/0001256928-09-000011
4//SEC Filing

RADY JANE E 4

Accession 0001256928-09-000011

CIK 0001168335other
View on SEC.govCompany Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 7:55 PM ET

Size

55.0 KB

Accession

0001256928-09-000011

Insider Transaction Report

Form 4
Period: 2009-02-25
ABBOTT MEDICAL OPTICS INCEYE
RADY JANE E
Other
Transactions
  • Disposition from Tender

    Common Stock

    2009-02-25$22.00/sh−66$1,452→ 0 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−5,760$126,720→ 0 total
  • Award

    Common Stock

    2009-02-25+364→ 364 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−167$3,676→ 197 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−197$4,334→ 0 total
  • Award

    Common Stock

    2009-02-25+1,399→ 1,399 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−641$14,108→ 758 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−758$16,676→ 0 total
  • Award

    Common Stock

    2009-02-25+1,560→ 1,560 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−714$15,715→ 846 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−846$18,612→ 0 total
  • Award

    Common Stock

    2009-02-25+473→ 473 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−217$4,776→ 256 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−256$5,632→ 0 total
  • Award

    Common Stock

    2009-02-25+1,055→ 1,055 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−483$10,631→ 572 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−1,215$26,730→ 0 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−498$10,961→ 590 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−590$12,980→ 0 total
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-26−29,000→ 0 total
    Exercise: $45.26From: 2009-02-25Exp: 2016-05-24→ Common Stock (29,000 underlying)
  • Award

    Common Stock

    2009-02-25+1,088→ 1,088 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−572$12,584→ 0 total
  • Award

    Common Stock

    2009-02-25+2,240→ 2,240 total
  • Tax Payment

    Common Stock

    2009-02-25$22.01/sh−1,025$22,560→ 1,215 total
  • Disposition to Issuer

    Common Stock

    2009-02-26$22.00/sh−1.984$44→ 0 total(indirect: By Trust)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-26−60,000→ 0 total
    Exercise: $33.72From: 2008-05-20Exp: 2014-05-20→ Common Stock (60,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-26−45,000→ 0 total
    Exercise: $38.20From: 2009-02-25Exp: 2019-05-26→ Common Stock (45,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-26−36,500→ 0 total
    Exercise: $42.55From: 2009-02-25Exp: 2017-05-21→ Common Stock (36,500 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2009-02-26−35,000→ 0 total
    Exercise: $22.94From: 2009-02-25Exp: 2018-05-29→ Common Stock (35,000 underlying)
Footnotes (10)
  • [F1]These shares were tendered to Rainforest Acquisition Inc. ("Purchaser") pursuant to Purchaser?s offer to purchase all of the outstanding shares of Advanced Medical Optics, Inc. (the "Issuer") at a cash purchase price of $22.00 per share, without interest, and subject to any required withholding taxes, subject to the terms described in the Offer to Purchase, filed with the SEC on January 27, 2009, as amended (the "Tender Offer"). Such shares were purchased by Purchaser pursuant to the Tender Offer on February 25, 2009.
  • [F10]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 14,360 shares of Abbott Laboratories common stock at an exercise price of $55.92 per share, determined pursuant to a formula set forth in the Merger Agreement.
  • [F2]These shares were canceled pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Rainforest Acquisition Inc. ("Purchaser") and the Issuer (the "Merger Agreement"), in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes) at the effective time of the merger.
  • [F3]Exempt restricted shares of common stock forfeited in connection with termination of employment were reinstated pursuant to change in control agreement.
  • [F4]Shares withheld in satisfaction of tax obligations attributable to the lapse of restrictions on stock award or in satisfaction of tax withholding attributable to vesting and settlement of restricted stock units.
  • [F5]The exempt restricted stock units (previously reported on Table II) that had been forfeited in connection with the reporting person's termination of employment were reinstated pursuant to a change in control agreement, vested in full and were settled for shares of Issuer Common Stock in accordance with the terms of the applicable equity plan. At the effective time of the merger, such shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes).
  • [F6]This previously reported exempt stock option, which vested ratably over four years from the date of grant, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 24,617 shares of Abbott Laboratories common stock at an exercise price of $82.19 per share, determined pursuant to a formula set forth in the Merger Agreement.
  • [F7]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 18,463 shares of Abbott Laboratories common stock at an exercise price of $93.11 per share, determined pursuant to a formula set forth in the Merger Agreement.
  • [F8]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 11,898 shares of Abbott Laboratories common stock at an exercise price of $110.32 per share, determined pursuant to a formula set forth in the Merger Agreement.
  • [F9]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 14,975 shares of Abbott Laboratories common stock at an exercise price of $103.71 per share, determined pursuant to a formula set forth in the Merger Agreement.

Documents

1 file

Issuer

ABBOTT MEDICAL OPTICS INC

CIK 0001168335

→
Entity typeother

Related Parties

1
  • filerCIK 0001227306

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:55 PM ET
Size
55.0 KB
View on SEC.gov